Steven Wolff, M.D.
Professor of Medicine

Internal Medicine

Phone: (615) 327-6277

1005 Dr. D.B. Todd Boulevard
Old Hospital Building
Nashville, TN  37208

Email: swolff@mme.edu

CV or Bio (PDF)

1965-1969 Queens College New Yourk, NY - B.A.

Clinical trials in hematology/oncology and education of trainess in cancer biology and clinical research.

Wolff SN, Herzig RH, Fay JW, Phillips GL, Lazarus HM, Flexner JM, Stein RS, Cooper B, Herzig GP. High-Dose Cytosine Arabinoside and Daunorubicin as Consolidation Therapy for Acute Myeloid Leukemia in First Remission: Long-Term Follow-Up and Results.  J of Clin Oncol 7:1260-1267,1989.

Wolff, SN. Second Hematopoietic Stem Cell Transplantation for the Treatment of Graft Failure, Graft Rejection or Relapse after Allogeneic Transplantation.  Bone Marrow Transplantation 2002 Apr;29(7):545-552.

Engelbardt, B, Holland, D, Brandt, S et al.  High-dose chemotherapy followed by autologous stem cell transplantation for relapsed or refractory Hodgkin’s Lymphoma: Prognostic features and outcomes.  Leukemia and Lymphoma 48: 1728-1735, 2007.

Wujcik, D., Wolff, SN. Recruitment of African-Americans to National Clinical Trials through a Share Clinical Trial Resource, Journal of Health Care for the Poor and Underserved. 2010: 21: 38-50.

Horn, L,  Zhao, Z, Sandler, A, Johnson, D, Shyr, Y, Wolff, S, DeVore, R, Laskin, J. A Phase II Study of Carboplatin and Irinotecan in Extensive Stage Small-Cell Lung Cancer. Clinical Lung Cancer, 2011: Vol. 12, No. 3, 161-5.